Viewing Study NCT00236756

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2026-01-25 @ 3:54 AM
Study NCT ID: NCT00236756
Status: COMPLETED
Last Update Posted: 2011-06-03
First Post: 2005-10-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
None Seizures View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epilepsy View
None Seizures View
None Topiramate View
None Prophylaxis View
None Antiepileptic View
None Lennox-Gastaut syndrome View
None Seizures, tonic View